Biologic activities of recombinant human-betadefensin-4 toward cultured human cancer cells

Experimental Oncology

Volumn 35, Issue 2, 2013, Pages 76-82

  Gerashchenko, O L ^a   Zhuravel, E V ^a   Skachkova, O V ^b   Khranovska, N N ^b   Filonenko, V V ^c   Pogrebnoy, P V ^a   Soldatkina, M A ^a  

^a R E KAVETSKY INSTITUTE OF EXPERIMENTAL PATHOLOGY   (Ukraine)

^b NATIONAL CANCER INSTITUTE   (Ukraine)

^c INSTITUTE OF MOLECULAR BIOLOGY AND GENETICS   (Ukraine)

Author keywords

Cancer cell; Colony forming activity; Human beta defensin 4; Migration; Proliferation

Indexed keywords

COMPLEMENTARY DNA; HYBRID PROTEIN; RECOMBINANT HUMAN BETA DEFENSIN 4; RECOMBINANT PROTEIN; THROMBIN; UNCLASSIFIED DRUG;

AFFINITY CHROMATOGRAPHY; ARTICLE; BACTERIAL CELL; BACTERIAL VIABILITY; BIOLOGICAL ACTIVITY; CANCER CELL CULTURE; CELL COUNT; CELL CYCLE PROGRESSION; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ESCHERICHIA COLI; FLOW CYTOMETRY; G2 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; IN VITRO STUDY; MOLECULAR CLONING; PROTEIN CLEAVAGE; PROTEIN PURIFICATION; RECOMBINANT PLASMID; REVERSED PHASE LIQUID CHROMATOGRAPHY;

ANTINEOPLASTIC AGENTS; BETA-DEFENSINS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; PROTEIN ENGINEERING; RECOMBINANT FUSION PROTEINS; TUMOR STEM CELL ASSAY;

EID: 84880875182     PISSN: 18129269     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Guaní-Guerra E, Santos-Mendoza T, Lugo-Reyes SO, Terán LM. Antimicrobial peptides: general overview and clinical implications in human health and disease. Clin Immunol 2010; 135: 1-11.
2. Schutte BC, Mitros JP, Bartlett JA, et al. Discovery of five conserved beta-defensin gene clusters using a computational search strategy. Proc Natl Acad Sci USA 2002; 99: 2129-33.
3. Bensch KW, Raida M, Mägert HJ, et al. hBD- 1: a novel beta-defensin from human plasma. FEBS Lett 1995; 368: 331-5.
4. Valore EV, Park CH, Quayle AJ, et al. Human β-defensin-1: an antimicrobial peptide of urogenital tissues. J Clin Invest 1998; 101: 1633-42.
5. Harder J, Bartels J, Christophers E, Schröder JM. A peptide antibiotic from human skin. Nature 1997; 387: 861.
6. Diamond G, Kaiser V, Rhodes J, et al. Transcriptional regulation of β-defensin gene expression in tracheal epithelial cells. Infect Immun 2000; 68: 113-9.
7. García JR, Jaumann F, Schulz S, et al. Identification of a novel, multifunctional beta-defensin (human betadefensin 3) with specific antimicrobial activity. Its interaction with plasma membranes of Xenopus oocytes and the induction of macrophage chemoattraction. Cell Tissue Res 2001; 306: 257-64.
8. García JR, Krause A, Schulz S, et al. Human β-defensin 4: a novel inducible peptide with a specific salt-sensitive spectrum of antimicrobial activity. FASEB J 2001; 15: 1819-21.
9. Harder J, Bartels J, Christophers E, Schroder JM. Isolation and characterization of human β-defensin-3, a novel human inducible peptide antibiotic. J Biol Chem 2001; 276: 5707-13.
10. Auvynet C, Rosenstein Y. Multifunctional host defense peptides: antimicrobial peptides, the small yet big players in innate and adaptive immunity. FEBS J 2009; 276: 6497-508.
11. Kohlgraf KG, Pingel LC, Dietrich DE, Brogden KA. Defensins as anti-inflammatory compounds and mucosal adjuvants. Future Microbiol 2010; 5: 99-113.
12. Niyonsaba F, Ushio H, Nakano N, et al. Antimicrobial peptides human beta-defensins stimulate epidermal keratinocyte migration, proliferation and production of proinflammatory cytokines and chemokines. Invest Dermatol 2007; 127: 594-604.
13. Gibson AL, Thomas-Virnig CL, Centanni JM, et al. Nonviral human beta defensin-3 expression in a bioengineered human skin tissue: a therapeutic alternative for infected wounds. Wound Repair Regen 2012; 20: 414-24.
14. Baroni A, Donnarumma G, Paoletti I, et al . Antimicrobial human beta-defensin-2 stimulates migration, proliferation and tube formation of human umbilical vein endothelial cells. Peptides 2009; 30: 267-72.
15. Frye M, Bargon J, Gropp R. Expression of human beta-defensin-1 promotes differentiation of keratinocytes. J Mol Med 2001; 79: 275-82.
16. Winter J, Pantelis A, Reich R, et al. Human betadefensin- 1, -2, and -3 exhibit opposite effects on oral squamous cell carcinoma cell proliferation. Cancer Invest 2011; 29: 196-201.
17. Bullard RS, Gibson W, Bose SK, et al. Functional analysis of the host defense peptide human beta defensin-1: new insight into its potential role in cancer. Mol Immunol 2008; 45: 839-48.
18. Sun CQ, Arnold R, Fernandez-Golarz C, et al. Human beta-defensin-1, a potential chromosome 8p tumor suppressor: control of transcription and induction of apoptosis in renal cell carcinoma. Cancer Res 2006; 66: 8542-9.
19. Kesting MR, Stoeckelhuber M, Kuppek A, et al. Human β-defensins and psoriasin/S100A7 expression in salivary glands: anti-oncogenic molecules for potential therapeutic approaches. BioDrugs 2012; 26: 33-42.
20. Shestakova T, Zhuravel E, Bolgova L, et al. Immunohistochemical analysis of beta-defensin-2 expression in human lung tumors. Exp Oncol 2010; 32: 273-6.
21. Zhuravel E, Shestakova T, Efanova O, et al. Human beta-defensin-2 controls cell cycle in malignant epithelial cells: in vitro study. Exp Oncol 2011; 33: 114-21.
22. Scola N, Gambichler T, Saklaoui H, et al. The expression of antimicrobial peptides is significantly altered in cutaneous squamous cell carcinoma and precursor lesions. Br J Dermatol 2012; 167: 591-7.
23. Mburu YK, Abe K, Ferris LK, et al. Human β-defensin 3 promotes NF-κB-mediated CCR7 expression and antiapoptotic signals in squamous cell carcinoma of the head and neck. Carcinogenesis 2011; 32: 168-74.
24. Jin G, Kawsar HI, Hirsch SA, et al. An antimicrobial peptide regulates tumor-associated macrophage trafficking via the chemokine receptor CCR2, a model for tumorigenesis. PLoS One 2010; 5: e10993.
25. Droin N, Hendra JB, Ducoroy P, Solary E. Human defensins as cancer biomarkers and antitumour molecules. J Proteomics 2009; 72: 918-27.
26. Coffelt SB, Scandurro AB. Tumors sound the alarmin(s). Cancer Res 2008; 68: 6482-5.
27. Shestakova T, Zhuravel E, Bolgova L, et al. Expression of human beta-defensins-1, -2 and -4 mRNA in human lung tumor tissue: a pilot study. Exp Oncol 2008; 30: 153-6.
28. Lisovskiy IL, Markeeva NV, Shnitsar VM, et al. Production of recombinant of hBD-2 - human antimicrobial peptide expressed in cervical and vulval cancer. Exp Oncol 2003; 25: 36-9.
29. Mosman T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. Immunol Methods 1983; 65: 55-63.
30. Lehrer RI, Rosenman M, Harwig S, et al. Ultrasensitive assays for endogenous antimicrobial polypeptides. J Immun Methods 1991; 137: 167-73.
31. Lampugnani MG. Cell migration into a wounded area in vitro. Methods Mol Biol 1999; 96: 177-82.
32. Xu MJ, Tsuji K, Ueda T, et al. Stimulation of mouse and human primitive hematopoiesis by murine embryonic aorta-gonad-mesonephros-derived stromal cell lines. Blood 1998; 92: 2032-40.
33. Supp DM, Gardner J, Klingenberg JM, Neely AN. Antibiotic resistance in clinical isolates of Acinetobacter baumannii, Pseudomonas aeruginosa, and Staphylococcus aureus does not impact sensitivity to human beta defensin 4. Burns 2009; 35: 949-55.
34. Pinheiro da Silva F, Machado MC. Antimicrobial peptides: clinical relevance and therapeutic implications. Peptides 2012; 36: 308-14.
35. Huang L, Leong SS, Jiang R. Soluble fusion expression and characterization of bioactive human beta-defensin 26 and 27. Appl Microbiol Biotechnol 2009; 84: 301-8.
36. Yanagi S, Ashitani J, Ishimoto H, et al. Isolation of human beta-defensin-4 in lung tissue and its increase in lower respiratory tract infection. Respir Res. 2005; 6: 130-9.
37. Otte JM, Neumann HM, Brand S, et al. Expression of beta-defensin 4 is increased in human gastritis. Eur J Clin Invest 2009; 39:126-38.